Publications by the researcher in collaboration with J. Sevilla Navarro (66)

2024

  1. Role of the mesenchymal stromal cells in bone marrow failure of Fanconi Anemia patients

    Frontiers in Cell and Developmental Biology, Vol. 12

2023

  1. Adverse events related to central venous catheters (CVC) and the influence of CVC characteristics on peripheral blood hematopoietic progenitor cell collection in children

    Frontiers in Pediatrics, Vol. 11

2022

  1. Extracorporeal photopheresis in paediatric patients: A retrospective comparison between different ‘off-line’ protocols

    Vox Sanguinis, Vol. 117, Núm. 10, pp. 1220-1229

  2. Mobilization with high-dose granulocyte colony-stimulating factor alone at 12 μg/kg twice a day in high-risk pediatric patients: A retrospective analysis of the experience in a single center

    Journal of Clinical Apheresis, Vol. 37, Núm. 5, pp. 420-429

2021

  1. Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes

    HemaSphere, Vol. 5, Núm. 4

  2. Plerixafor-based mobilization in pediatric healthy donors with unfavorable donor/recipient body weight ratio resulted in a better CD34+ collection yield: A retrospective analysis

    Journal of Clinical Apheresis, Vol. 36, Núm. 1, pp. 78-86

2016

  1. Hemiparesis in an adolescent with Acute lymphoblastic leukemia: Everything is not always what it seems

    Journal of Pediatric Hematology/Oncology, Vol. 38, Núm. 1, pp. 63-64

  2. IgA-Mediated Autoimmune Hemolytic Anemia: A Clinical Conundrum

    Pediatric Blood and Cancer

  3. Immunomagnetic T cell depletion: An analysis of variables affecting final cell yield

    Clinical Laboratory, Vol. 62, Núm. 7, pp. 1243-1248

2015

  1. Coloración anormal del suero asociado al tratamiento con eltrombopag, en paciente con trombopenia inmune

    Revista Espanola de Pediatria, Vol. 71, Núm. 1, pp. 39-41

2013

  1. Actualización del tratamiento con L-asparraginasa en Pediatría

    Anales de Pediatria, Vol. 79, Núm. 5

  2. Defining "poor mobilizer" in pediatric patients who need an autologous peripheral blood progenitor cell transplantation

    Cytotherapy, Vol. 15, Núm. 1, pp. 132-137

  3. Rituximab en el tratamiento de citopenias autoinmunitarias refractarias a tratamientos convencionales

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 78, Núm. 6, pp. 398-404

  4. Transformación de síndrome mielodisplásico a leucemia linfoblástica aguda: 2 casos nuevos

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 78, Núm. 6, pp. 393-397

2012

  1. Priming of hematopoietic progenitor cells by plerixafor and filgrastim in children with previous failure of mobilization with chemotherapy and/or cytokine treatment

    Journal of Pediatric Hematology/Oncology, Vol. 34, Núm. 2, pp. 146-150

2011

  1. Candidiasis hepatoesplénica en pacientes hemato-oncológicos pediátricos

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 75, Núm. 1, pp. 26-32

  2. Chromosome fragility in patients with Fanconi anaemia: Diagnostic implications and clinical impact

    Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 242-250

  3. Origin, functional role, and clinical impact of fanconi anemia fanca mutations

    Blood, Vol. 117, Núm. 14, pp. 3759-3769

  4. ¿Cuál es el pronóstico de la trombopenia inmunitaria crónica?

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 74, Núm. 5, pp. 317-323

2010

  1. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk ewing sarcoma patients: A long-term follow-up single-center study

    Pediatric Hematology and Oncology, Vol. 27, Núm. 4, pp. 272-282